1. Market Research
  2. > Pathology
Customer Support

Talk to Ahmad

+1 718 618 4302

Top Countries

  • All
    • Australasia

Companies

  • All
    • Novartis AG

Publishers

2 reports for Lymphoma (page 1)

Purchase Reports From Reputable Market Research Publishers

Age-Related Macular Degeneration: Global Drug Forecast and Market Analysis to 2028

  • $ 10995
  • April 2020
  • 204 pages

Age-Related Macular Degeneration: Global Drug Forecast and Market Analysis to 2028 Summary Age-related macular degeneration (AMD) is an eye condition that is characterized by the gradual deterioration ...

  • Lymphoma
  • Targeted Therapy
  • Therapy
  • Australasia
  • Novartis AG

PharmaPoint: Melanoma - Global Drug Forecast and Market Analysis to 2026

  • $ 10995
  • September 2017
  • 433 pages

PharmaPoint: Melanoma - Global Drug Forecast and Market Analysis to 2026 Summary Melanoma is the deadliest and most aggressive form of skin cancer. Melanoma is rare compared to other major cancer indications, ...

  • Hospital
  • Lymphoma
  • Therapy
  • Australasia
  • Novartis AG


View report >

Therapy Market in New Zealand and Australasia

  • May 2009
  • 181 pages

Immunology and Infectious Disease ARCOXIA treatment for signs and symptoms of arthritis Hepatitis A vaccine A##A TEMODAL ONCOTICE CAELYX INTRON A M##A REMICADE Brain tumour treatment bladder cancer treatment breast L##D cancer treatment Forms of leukaemia, lymphoma, malignant melanoma and mult

  • Lymphoma
  • Therapy
  • Australasia
  • New Zealand
  • Novartis AG

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on